70
https://pubmed.ncbi.nlm.nih.gov/38117953
A new compound that inhibits both autophagy and REV-ERB shows promising results as a potential anticancer drug in a melanoma xenograft model.
“Novel Compound Inhibiting Autophagy and REV-ERB Shows Potential as Anticancer Drug in Melanoma Xenograft Model”
